Skip to main content
. 2022 Jul 8;5(4):87–98. doi: 10.31547/bct-2022-002

Figure 2. Trends in the total number of transplants by main disease indication. Total number of transplants in 2017: (A) >1,000, (B) <1,000.

Figure 2.

AML, acute myelogenous leukemia; PCD, plasma cell disorders; ML, malignant lymphoma; ALL, acute lymphoblastic leukemia; MDS, myelodysplastic syndrome; MDS/MPN, myelodysplastic/myeloproliferative neoplasm; SAA, severe aplastic anemia; CML, chronic myeloid leukemia